Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Site Map
2023
January
06
QuidelOrtho expects Q4 revenues between $853 million and $868 million
Alveo Technologies, Government of Barbados collaborate to develop molecular diagnostic tests for many markets
Agilent Technologies, Akoya Biosciences partner to develop multiplex immunohistochemistry assays for tissue analysis
Molecular diagnostic firm Biocept to reduce staff by about 35% in restructuring
Page 1 of 1